Data / Form D filings / ENZO BIOCHEM INC
ENZO BIOCHEM INC: Form D filing
ENZO BIOCHEM INC, a health care company in Farmingdale, NY, filed a Form D with the SEC in 2023. The latest, on June 5, 2023, reports $7 million sold of a $7 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 81 EXECUTIVE BLVD., SUITE 3, Farmingdale, NY, 11735
- Phone
- (631) 755-5500
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- New York
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 316253
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 5, 2023 | New notice | $7,000,000 | $7,000,000 | 3 | May 19, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Elazar L. Rabbani, Ph.D. | Director | |
| Bradley L. Radoff | Director | |
| Patricia Eckert | Executive Officer | |
| Ian L. Walters, M.D. | Director | |
| Hamid Erfanian | Executive Officer, Director | |
| Dieter Schapfel, M.D. | Executive Officer | |
| Kara Cannon | Executive Officer | |
| Matthew Kupferberg | Executive Officer | |
| Mary L. Tagliaferri, M.D. | Director |
Other health care companies in New York that filed recently
- MOCEAN HOLDINGS Corp $1.5 million · Oct 27, 2026
- Frictionworx Inc. $40,000 · Oct 13, 2026
- Atmos Clinic, Inc. $6 million · Oct 8, 2026
- PreciseDx, Inc. $3.7 million · Oct 7, 2026
- Amani Therapeutics, Inc. $35 million · Oct 1, 2026
- Click Therapeutics, Inc. $50 million · Oct 1, 2026
Every Form D from the week of Jun 5, 2023 · All recent filings in New York · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what ENZO BIOCHEM INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.